Mattar SG et al. (2005) Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 242: 610–620
The incidence of nonalcoholic fatty liver disease (NAFLD) is rising steadily; this might be caused by its association with severe obesity and metabolic syndrome. In a recent study, Mattar et al. examined the outcomes of laparoscopic weight-loss procedures in severely obese patients with NAFLD.
Overall, 70 patients were included in this study. Patients included in the study had undergone laparoscopic weight-loss surgery at the University of Pittsburgh, US between March 1999 and August 2004, had a diagnosis of NAFLD, and had agreed to undergo serial liver biopsies.
Postoperatively, patients experienced a loss of excess mean body weight of 59% ± 22%. Major improvements were also noted in the biochemical markers of metabolic syndrome, fasting blood glucose and hemoglobin A1c. Furthermore, there were marked improvements in liver steatosis (from 88% to 8%), inflammation (from 23% to 2%) and fibrosis (from 31% to 13%). Inflammation and fibrosis also resolved in 37% and 20% of patients, respectively.
The authors highlight the importance of obesity and, in turn, metabolic syndrome, in the NAFLD disease process. The authors conclude that surgical weight-loss procedures significantly improve NAFLD in obese patients, as a significant proportion experienced reversal of liver disease; furthermore, there were no deaths and few complications. Further studies are needed, however, to define the interactions between obesity, metabolic syndrome, and NAFLD.
Rights and permissions
About this article
Cite this article
Lofthouse, M. Improvement in NAFLD after laparoscopic weight-loss surgery. Nat Rev Endocrinol 2, 6 (2006). https://doi.org/10.1038/ncpendmet0062
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0062